Verdelho Miguel, Perdigoto Rui, Machado João, Mateus Élia, Marcelino Paulo, Pereira Rui, Fortuna Philip, Bagulho Luís, Bento Luís, Ribeiro Francisco, Nolasco Fernando, Martins Américo, Barroso Eduardo
Department of Nephrology, Hospital Curry Cabral, Centro Hospitalar Lisboa Central, Lisbon, Portugal.
Department of Transplantation, Hospital Curry Cabral, Centro Hospitalar Lisboa Central, Lisbon, Portugal.
GE Port J Gastroenterol. 2018 Jan;25(1):18-23. doi: 10.1159/000478988. Epub 2017 Aug 24.
Acute-on-chronic liver failure (ACLF) is a syndrome characterized by an acute deterioration of a patient with cirrhosis, frequently associated with multi-organ failure and a high short-term mortality rate. We present a retrospective study that aims to characterize the presentation, evolution, and outcome of patients diagnosed with ACLF at our center over the last 3 years, with a comparative analysis between the group of patients that had ACLF precipitated by infectious insults of bacterial origin and the group of those with ACLF triggered by a nonbacterial infectious insult; the incidence of acute kidney injury and its impact on the prognosis of ACLF was also analyzed. Twenty-nine patients were enrolled, the majority of them being male (89.6%), and the mean age was 53 years. Fourteen patients (48.3%) developed ACLF due to a bacterial infectious event, and 9 of them died (64.2%, overall mortality rate 31%); however, no statistical significance was found ( < 0.7). Of the remaining 15 patients (51.7%) with noninfectious triggers, 11 died (73.3%, overall mortality rate 37.9%); again there was no statistical significance ( < 0.7). Twenty-four patients (83%) developed acute kidney injury (overall mortality rate 65.5%; < 0.022) at the 28-day and 90-day follow-up. Twelve patients had acute kidney injury requiring renal replacement therapy (41.37%; overall mortality rate 37.9%; < 0.043). Hepatic transplant was performed in 3 patients, with a 100% survival at the 28-day and 90-day follow-up ( < 0.023). Higher grades of ACLF were associated with increased mortality ( < 0.02; overall mortality 69%).
ACLF is a heterogeneous syndrome with a variety of precipitant factors and different grades of extrahepatic involvement. Most cases will have some degree of renal dysfunction, with an increased risk of mortality. Hepatic transplant is an efficient form of therapy for this syndrome.
慢加急性肝衰竭(ACLF)是一种以肝硬化患者急性恶化为特征的综合征,常伴有多器官功能衰竭和高短期死亡率。我们进行了一项回顾性研究,旨在描述过去3年在我们中心被诊断为ACLF的患者的临床表现、病情演变和预后,并对由细菌源性感染性损伤引发ACLF的患者组与由非细菌性感染性损伤引发ACLF的患者组进行比较分析;还分析了急性肾损伤的发生率及其对ACLF预后的影响。共纳入29例患者,其中大多数为男性(89.6%),平均年龄为53岁。14例患者(48.3%)因细菌感染事件发生ACLF,其中9例死亡(64.2%,总死亡率31%);然而,未发现统计学意义(<0.7)。其余15例(51.7%)由非感染性诱因导致ACLF的患者中,11例死亡(73.3%,总死亡率37.9%);同样未发现统计学意义(<0.7)。24例患者(83%)在28天和90天随访时发生急性肾损伤(总死亡率65.5%;<0.022)。12例患者的急性肾损伤需要肾脏替代治疗(41.37%;总死亡率37.9%;<0.043)。3例患者接受了肝移植,在28天和90天随访时生存率为100%(<0.023)。ACLF分级越高,死亡率越高(<0.02;总死亡率69%)。
ACLF是一种异质性综合征,有多种诱发因素和不同程度的肝外受累。大多数病例会有一定程度的肾功能不全,死亡率增加。肝移植是治疗该综合征的有效方法。